Biggest News Aggregation in the World
๐Ÿ“ฐ Looking Statement News

Page 14 - Looking Statement News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Looking Statement. Real-time updates on events, politics, business and more.

Merck Announces KEYLYNK-008 Trial Evaluating KEYTRUDA (pembrolizumab) Plus LYNPARZA (olaparib) for Patients With Metastatic Squamous Non-Small Cell Lung Cancer to Stop for Futility

07.12.2023 - Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that it will stop the Phase 3 KEYLYNK-008 trial evaluating KEYTRUDA, Merckโ€™s anti-PD-1 therapy, in combination with maintenance LYNPARZA, a PARP inhibitor, for ...
United States Merck Research Laboratories Merck Co Stock Statement Of Merck Co Inc Exchange Commission Merck Co Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science